Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Supreme Court May Be Next After Federal Circuit Refuses To Rehear Teva Inhaler Patents Case
Mar 20 2025
•
By
Urtė Fultinavičiūtė
If the appeals court decision stands, companies could decide to voluntarily delist some patents from the Orange Book.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Generics
More from Patents